NHE-1 inhibition: From protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 4, 2003, Pages 239-246

  Linz, Wolfgang J ^a   Busch, Andreas E ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Cariporide; Hypertrophy; Ischaemia; Myocardial remodelling; NHE 1; Reperfusion

Indexed keywords

(3 METHYLSULFONYL 4 PIPERIDINOBENZOYL)GUANIDINE METHANESULFONATE; 1 (3,4 DIHYDRO 4 ISOPROPYL 2,2 DIMETHYL 3 OXO 2H 1,4 BENZOXAZINE 6 CARBONYL)GUANIDINE; 5 (N ETHYL N ISOPROPYL)AMILORIDE; ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; AMILORIDE; ANGIOTENSIN; BRADYKININ; CARDIOVASCULAR AGENT; CARIPORIDE; ENDOTHELIN 1; ENIPORIDE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; N AMIDINO 1,4 DIMETHYL 1H INDOLE 2 CARBOXAMIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 1 INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN 2; SODIUM PROTON EXCHANGE PROTEIN 3; SODIUM PROTON EXCHANGE PROTEIN 4; SODIUM PROTON EXCHANGE PROTEIN 5; SODIUM PROTON EXCHANGE PROTEIN 6; SODIUM PROTON EXCHANGE PROTEIN 7; SODIUM PROTON EXCHANGE PROTEIN 8; THROMBIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE HEART INFARCTION; CLINICAL TRIAL; HEART HYPERTROPHY; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PROTON SODIUM EXCHANGE; REVIEW; SODIUM CALCIUM EXCHANGE; TRANSPORT KINETICS;

ANIMALS; CARDIOMYOPATHIES; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUROTRANSMITTER AGENTS; SODIUM-HYDROGEN ANTIPORTER; VENTRICULAR REMODELING;

EID: 0242643761     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0808-2     Document Type: Review

References (99)

1. + exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol 150:213-224
2. + exchanger delays the development of rapid pacing-induced atrial contractile dysfunction. Circulation 103:762-768
3. + exchange inhibitors: potential mechanisms of action. Basic Res Cardiol 96:306-311
4. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Col Cardiol 39:747-753
5. + exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress. J Thromb Thrombolysis 8:25-31
6. + exchanger. Br J Pharmacol 131:659-662
7. Ayoub IM, Kolarova J, Yi Z, Trevedi A, Deshmukh H, Lubell DL, Franz MR, Maldonado FA, Gazmuri RJ (2003) Sodium-hydrogen exchange inhibition during ventricular fibrillation. Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 107:1804-1809
8. +] and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57:1015-1024
9. + exchanger isoform 5 (NHE5) from human brain. J Biol Chem 274:4377-4382
10. Becker RHA, Linz W, Schölkens BA (1989) Pharmacological interference with the cardiac renin angiotensin system. J Cardiovasc Pharmacol 14 (suppl. 4):S10-S15
11. + exchanger (NHE-1 isoform) in response to growth factors. J Biol Chem 272:271-279
12. + exchanger isoform of renal brush border. Am J Physiol 265:F736-F742
13. + exchanger isoforms NHE2 and NHE4 in rat intestine and kidney. Am J Physiol 273:C1496-C1505
14. + exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. Am J Physiol 282:C1031-C1041
15. + exchanger gene family. J Nephrol 15 (suppl. 5):S3-S21
16. + exchanger. Cardiovasc Res 53:862-868
17. + exchange inhibitor cariporide. J Pharmacol Exp Ther 298:469-476
18. + exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc Res 44:462-467
19. + exchange inhibition. Hypertension 41:373-377
20. Clerk A, Sugden PH (1999) Activation of protein kinase cascades in the heart by hypertrophic G protein coupled receptor agonists. Am J Cardiol 83:64H-69H
21. + exchangers. J Biol Chem 275:1-4
22. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 44:1041-1045
23. + exchanger mRNA levels in ischemic hearts from diabetic rats. Mol Cell Biochem 180:85-93
24. Dyck JRB, Maddaford T, Pierce GN, Fliegel L (1995) Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res 29:203-208
25. + exchange prevents hypertrophy, fibrosis, and heart failure in β1-adrenergic receptor transgenic mice. Circ Res 90:814-819
26. Erhardt LR (1999) GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol 83:23G-25G
27. + exchanger. J. Thromb Thrombol 8:9-14
28. + exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res 36:138-148
29. Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S (2003) Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury. Hypertension 41:493-498
30. + exchange isoform 1 mRNA expression in isolated rat hearts. Am J Physiol 277:H993-H998
31. Gazmuri RJ, Hoffner E, Kalcheim J, Ho H, Patel M, Ayoub IM, Epstein M, Kingston S, Han Y (2001) Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med 137:43-55
32. Gazmuri RJ, Ayoub IM, Kolarova JD, Karmazyn M (2002) Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med 30:S166-S171
33. + exchanger isoform NHE-8. Am J Physiol 284:F467-F473
34. + exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation 100:2519-2526
35. + exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol 396:119-124
36. Gumina RJ, Terzic A, Gross GJ (2001) Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism? Basic Res Cardiol 96:318-324
37. Haist JV, Hirst CN, Karmazyn M (2003) Effective protection by NHE1 inhibition in ischemic and reperfused heart under preconditioning blockade. Am J Physiol 284:H798-H803
38. + exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc Drugs Ther 9:823-826
39. Hileeto D, Cukiernik M, Mukherjee S, Evans T, Barbin Y, Downey D, Karmazyn M, Chakrabarti S (2002) Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev 18:386-394
40. Hoogerwerf WA, Tsao SC, Devuyst O, Levine SA, Yun CH, et al. (1996) NHE2 and NHE3 are human and rabbit intestinal brushborder proteins. Am J Physiol 270:G29-G41
41. + exchange inhibition. Circ Res 87:1133-1140
42. Karmazyn M (2001) Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res Cardiol 96:325-328
43. + exchange inhibition. Drug Dev Res 55:22-28
44. + exchange: structure, regulation, and its role in heart disease. Circ Res 85:777-786
45. + exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559. Eur J Pharmacol 420:1-8
46. + exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual flow. Circulation 102:1977-1982
47. Knight DR, Smith AH, Flynn DM, MacAndrew JT, Ellery SS, Kong JX, Marala RB, Wester RT, Guzman-Perez A, Hill RJ, Magee WP, Tracey WR (2001) A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J. Pharmacol Exp Ther 297:254-259
48. + antiport and C1/HCO3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol 27:2521-2528
49. Kovar, A, Peters T, Beier N, Derendorf H (2001) Pharmacokinetic/ pharmacodynamic evaluation of the NHE inhibitor eniporide. J Clin Pharmacol 41:139-148
50. + exchange and ERK1/2. Circ Res 83: 824-831
51. + exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am J Physiol 280:H738-H745
52. Lin X, Barber DL (1996) A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. J Biol Chem 93: 12631-12636
53. Linz W, Jessen T, Becker RHA, Schölkens BA, Wiemer G (1997) Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 96:3164-3172
54. Linz W, Albus U, Crause P, Jung W, Weichert A, Schölkens BA, Scholz W (1998) Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens 20:733-749
55. Loennechen JP, Wisloff U, Falck G, Ellingsen O (2002) Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation 105:1380-1386
56. López-de León A, Rojkind M (1985) A simple method for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737-743
57. Lorrain J, Briand V, Favennec E, Duval N, Grosset A, Janiak P, Hoornaert C, Cremer G, Latham C, O'Connor S (2000) Pharmacological profile of SL59.1227, a novel inhibitor of the sodium/hydrogen exchanger. Br J Pharmacol 131:1188-1194
58. Meyer M, Lehnart S, Pieske B, Schlottauer K, Munk S, Holubarsch C, Just H, Hasenfuss G (1996) Influence of endothelin 1 on human atrial myocardium - myocardial function and subcellular pathways. Basic Res Cardiol 91:86-93
59. Moe OW (1999) Acute regulation of proximal tubule apical membrane Na/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol 10:2412-2425
60. + exchanger in the rat myocardium by MAP-kinase-dependent pathways. J Biol Chem 274:22985-229992
61. + exchanger in neonatal ventricular myocytes. J Mol Cell Cardiol 32:925-936
62. + exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium. J Biol Chem 276:16113-16122
63. + exchanger localized to the trans-Golgi network. J Biol Chem 276:17387-17394
64. + exchanger. J Biol Chem 273:6951-6959
65. + exchangers of mammalian cells. J Biol Chem 272:22373-22376
66. + exchange inhibitor cariporide (HOE 642) on cardiac function and cardiomyocyte cell death in rat ischaemic-reperfused heart. Clin Exp Pharmacol Physiol 27:387-393
67. Palmerini CA, Fini C, Floridi A, Morelli H, Vedovelli A (1985) High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine. J Chromatogr 339:285-292
68. + exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 42:527-552
69. + exchanger. J Biol Chem 266:2739-2745
70. + exchangers: linking osmotic dysequilibrium to modified cell function. Cell Physiol Biochem 11:1-18
71. - symporter in the rat heart after myocardial infarction. J Am Coll Cardiol 37:2154-2165
72. - symporter. Eur J Pharmacol 458:3-16
73. Schäfer M, Schäfer C, Piper H, Schlüter K-D (2002) Hypertrophic responsiveness of cardiomyocytes to α-or β-adrenoceptor stimulation requires sodium-proton-exchanger-1 (NHE-1) activation but not cellular alkalization. Eur J Heart Fail 4:249-254
74. i and creatine phosphate on α-adrenoceptor- mediated cardiac hypertrophy. J Mol Cell Cardiol 30:763-771
75. Scholz W, Albus U, Counillon L, Gögelein H, Lang HJ, Linz W, Weichert A, Schölkens BA (1995) Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion. Cardiovasc Res 29:260-268
76. + exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial. J Thromb Thrombolysis 8:61-70
77. + exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Can Cardiovasc Res 54:438-446
78. + exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc Res 46: 102-110
79. + exchanger kinase. Hypertension 29:1265-1272
80. + exchanger isoform-1. J Biol Chem 274:206-214
81. + antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cardiol 27:729-742
82. + exchange blocker, in a murine model of dilated cardiomyopathy. Res Commun Chem Pathol Pharmacol 92:201-210
83. Theroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson J-T, Jessel A (2000) Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102:3032-3038
84. Thompson K, Wisenberg G, Sykes RVT, Thompson RT (2003) MRI/MRS evaluation of cariporide in a canine long-term model of reperfused ischemic insults. J. Magn Reson Imaging. 17: 136-141
85. Touret N, Tanneur V, Godart H, Seidler R, Taki N, Bürger E, Dämmgen J, Counillon L (2003) Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur J Pharmacol. 459:151-158
86. Tracy WR, Allen MC, Frazier DE, Fossa AA, Johnson CG, Marala RB, Knight DR, Guzman-Perez A (2003) Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). Cardiovasc Drug Rev 21:17-32
87. + exchanger isoform (NHE-2). J Biol Chem 268:11917-11924
88. + exchanger NHE-1 through sequence specific interaction. Biochemistry 36:12854-12861
89. + exchanger isoform 1. J Biol Chem 275:7942-7949
90. + exchanger through mitogen-activated protein kinase. Biochemistry 36:9151-9158
91. 2+ signalling in rabbit ventricular myocytes. Br J Pharmacol 131:638-644
92. Wirth KJ, Maier T, Busch AE (2001) NHE-1 inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol 96:192-197
93. + exchange inhibitor, SM-20550, on ischemia/ reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. Int J Tissue React 23:1-7
94. Yamazaki T, Komuro I, Kudoh S, et al. (1998) Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res 82:430-437
95. + exchanger. Circ Res 79:705-715
96. + exchanger activity and expression in human ventricular myocardium. J Am Col Cardiol 36:534-540
97. + exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am J Physiol 278:H300-H304
98. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: results of the Evaluation of the Safety and Cardioprotective Effects of Eniporide in Acute Myocardial Infarction (ESCAMI) trial. J Am Coll Cardiol 38:1644-1650
99. Zolk O, Kouchi I, Schnabel P, Böhm M (2000) Heterotrimeric G proteins in heart disease. Can J Physiol Pharmacol 78:187-198